Development and Validation of the Cluster Headache Screening Questionnaire
Journal of Clinical Neurology
;
: 90-96, 2019.
Article
in English
| WPRIM
| ID: wpr-719294
ABSTRACT
BACKGROUND AND PURPOSE:
Cluster headache (CH) is frequently either not diagnosed or the diagnosis is delayed. We addressed this issue by developing the self-administered Cluster Headache Screening Questionnaire (CHSQ).METHODS:
Experts selected items from the diagnostic criteria of CH and the characteristics of migraine. The questionnaire was administered to first-visit headache patients at nine headache clinics. The finally developed CHSQ included items based on the differences in responses between CH and non-CH patients, and the accuracy and reliability of the scoring model were assessed.RESULTS:
Forty-two patients with CH, 207 migraineurs, 73 with tension-type headache, and 18 with primary stabbing headache were enrolled. The CHSQ item were scored as follows 3 points for ipsilateral eye symptoms, agitation, and duration; 2 points for clustering patterns; and 1 point for the male sex, unilateral pain, disability, ipsilateral nasal symptoms, and frequency. The total score of the CHSQ ranged from 0 to 16. The mean score was higher in patients with CH than in non-CH patients (12.9 vs. 3.4, p 8 points, the CHSQ had a sensitivity, specificity, positive predictive value, and negative predictive value of 95.2%, 96%, 76.9%, and 99.3%, respectively.CONCLUSIONS:
The CHSQ is a reliable screening tool for the rapid identification of CH.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Mass Screening
/
Prevalence
/
Sensitivity and Specificity
/
Cluster Headache
/
Tension-Type Headache
/
Diagnosis
/
Dihydroergotamine
/
Headache Disorders, Primary
/
Headache
/
Migraine Disorders
Type of study:
Diagnostic study
/
Prevalence study
/
Prognostic study
/
Screening study
Limits:
Humans
/
Male
Language:
English
Journal:
Journal of Clinical Neurology
Year:
2019
Type:
Article
Similar
MEDLINE
...
LILACS
LIS